Adult progenitor rejuvenation with embryonic factors

Author:

Wang Peng123,Liu Xupeng123,Chen Yu123,Jun‐Hao Elwin Tan4567,Yao Ziyue123,Min‐Wen Jason Chua4567,Yan‐Jiang Benjamin Chua4567,Ma Shilin123,Ma Wenwu123,Luo Lanfang123,Guo Luyao123,Song Dan123,Shyh‐Chang Ng123ORCID

Affiliation:

1. State Key Laboratory of Reproductive Biology, Institute of Zoology Chinese Academy of Sciences Beijing China

2. Beijing Institute for Stem Cell and Regenerative Medicine Institute for Stem Cell and Regeneration, Chinese Academy of Sciences Beijing China

3. University of Chinese Academy of Sciences Beijing China

4. NUS Graduate School for Integrative Sciences and Engineering National University of Singapore Singapore Singapore

5. Institute of Molecular and Cell Biology, Genome Institute of Singapore, Agency for Science Technology and Research Singapore Singapore

6. Laboratory of Cancer Therapeutics, Program in Cancer and Stem Cell Biology, Duke‐National University of Singapore Medical School Singapore Singapore

7. Laboratory of Cancer Epigenome, Division of Medical Science, National Cancer Centre Singapore Singapore Singapore

Abstract

AbstractDuring ageing, adult stem cells' regenerative properties decline, as they undergo replicative senescence and lose both their proliferative and differentiation capacities. In contrast, embryonic and foetal progenitors typically possess heightened proliferative capacities and manifest a more robust regenerative response upon injury and transplantation, despite undergoing many rounds of mitosis. How embryonic and foetal progenitors delay senescence and maintain their proliferative and differentiation capacities after numerous rounds of mitosis, remains unknown. It is also unclear if defined embryonic factors can rejuvenate adult progenitors to confer extended proliferative and differentiation capacities, without reprogramming their lineage‐specific fates or inducing oncogenic transformation. Here, we report that a minimal combination of LIN28A, TERT, and sh‐p53 (LTS), all of which are tightly regulated and play important roles during embryonic development, can delay senescence in adult muscle progenitors. LTS muscle progenitors showed an extended proliferative capacity, maintained a normal karyotype, underwent myogenesis normally, and did not manifest tumorigenesis nor aberrations in lineage differentiation, even in late passages. LTS treatment promoted self‐renewal and rescued the pro‐senescence phenotype of aged cachexia patients' muscle progenitors, and promoted their engraftment for skeletal muscle regeneration in vivo. When we examined the mechanistic basis for LIN28A's role in the LTS minimum combo, let‐7 microRNA suppression could not fully explain how LIN28A promoted muscle progenitor self‐renewal. Instead, LIN28A was promoting the translation of oxidative phosphorylation mRNAs in adult muscle progenitors to optimize mitochondrial reactive oxygen species (mtROS) and mitohormetic signalling. Optimized mtROS induced a variety of mitohormetic stress responses, including the hypoxic response for metabolic damage, the unfolded protein response for protein damage, and the p53 response for DNA damage. Perturbation of mtROS levels specifically abrogated the LIN28A‐driven hypoxic response in Hypoxia Inducible Factor‐1α (HIF1α) and glycolysis, and thus LTS progenitor self‐renewal, without affecting normal or TS progenitors. Our findings connect embryonically regulated factors to mitohormesis and progenitor rejuvenation, with implications for ageing‐related muscle degeneration.

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,General Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3